COR - Cencora
227.69
| Index: | S&P 500 | P/E: | 30.34 | EPS (ttm): | 7.51 | Insider Own: | 10.74% | Shs Outstand: | 194.94M | Perf Week: | -1.96% |
| Market Cap: | 44.28B | Forward P/E: | 13.90 | EPS next Y: | 16.38 | Insider Trans: | -17.97% | Shs Float: | 172.53M | Perf Month: | -6.38% |
| Income(ttm): | 1.51B | PEG: | 3.33 | EPS next Q: | 3.49 | Inst Own: | 91.75% | Short Float: | 5.86% | Perf Quarter: | -0.28% |
| Revenue(ttm): | 293.96B | P/S: | 0.15 | EPS this Y: | 8.83% | Inst Trans: | 0.34% | Short Ratio: | 7.21 | Perf Half Y: | -4.88% |
| Book/sh: | 3.31 | P/B: | 68.72 | EPS next Y: | 9.39% | ROA: | 2.33% | Short Interest: | 10.11M | Perf Year: | 13.96% |
| Cash/sh: | 16.61 | P/C: | 13.70 | EPS next 5Y: | 9.10% | ROE: | 258.42% | 52W Range: | 199.75 - 253.27 | Perf YTD: | 10.86% |
| Dividend Est.: | 2.16 (0.95%) | P/FCF: | 14.77 | EPS past 5Y: | 13.29% | ROI: | 27.50% | 52W High: | -10.10% | Beta: | 0.48 |
| Dividend TTM: | 2.08 (0.91%) | Quick Ratio: | 0.53 | Sales past 5Y: | 10.39% | Gross Margin: | 2.95% | 52W Low: | 13.99% | ATR (14): | 4.26 |
| Dividend Ex-Date: | Nov 15, 2024 | Current Ratio: | 0.88 | EPS Y/Y TTM: | -12.10% | Oper. Margin: | 1.02% | RSI (14): | 31.75 | Volatility: | 1.74% 1.74% |
| Employees: | 46000 | Debt/Eq: | 8.70 | Sales Y/Y TTM: | 12.12% | Profit Margin: | 0.51% | Recom: | 1.89 | Target Price: | 273.57 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 7.50 | EPS Q/Q: | -99.01% | Payout: | 27.07% | Rel Volume: | 1.39 | Prev Close: | 226.27 |
| Sales Surprise: | 1.84% | EPS Surprise: | 3.52% | Sales Q/Q: | 14.69% | Earnings: | Nov 06 BMO | Avg Volume: | 1.40M | Price: | 227.69 |
| SMA20: | -4.87% | SMA50: | -4.52% | SMA200: | -2.59% | Undervalued: 20.15% | Volume: | 1,942,692 | Change: | 0.63% | |
Graham Classic formula value: 180.06
(P/E=8 * 1g) Min value: 115.32
(current P/E * 2g) Max value: 327.34
Average value: 207.57
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.